Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on ...

In this study, we demonstrate that Snf1 and yeast glycogen synthase kinase 3-beta (GSK3-β) independently phosphorylate and activate Tda1, which in turn phosphorylates Hxk2 at Ser15. The Ser483 and ...

Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other ...

The webcast of the presentation will be accessible in the Investor section of the Actuate website. The Actuate management team will participate in one-on-one investor meetings during this event.

Gossamer Bio's seralutinib shows promise in PAH Phase 2 trials, but Phase 3 success is vital amidst competition. Click to ...

Stem cell-derived pancreatic islets are being studied as a rich transplantable source for insulin production, a therapeutic ...

We are also tracking any problems, the latest updates, and what’s new in the beta. The latest version of ... issued an update to Sequoia. macOS 15.3.2 brought bug fixes and one major security ...

As for performance, the largest Qwen3-235B-A22B model delivers competitive results along the lines of DeepSeek R1, Grok 3 Beta, Gemini 2.5 Pro, and OpenAI o1. What I find interesting is that the ...